Summary
For Year 2025-26, Vaishali Pharma reports the following shareholding: Total Promoters at 31.61%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0%, Domestic Institutional Investors at 0%, and Retail at 68.39%. This breakdown provides a quick snapshot of ownership distribution for Vaishali Pharma in 2025-26.
Vaishali Pharma FAQs
As of 02-2026, the promoter shareholding in Vaishali Pharma stands at 31.61% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Vaishali Pharma is 0% and 0% respectively.
The retail shareholding of the Vaishali Pharma is 68.39%.
Changes in shareholding patterns of Vaishali Pharma can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Vaishali Pharma are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
